Management ChangeJul 16, 2026, 05:26 PM
Silence Therapeutics Details Craig Tooman Separation Agreement
AI Summary
Silence Therapeutics plc has provided details regarding the separation agreement with Craig Tooman, whose employment ended on December 14, 2025. The agreement, entered into on July 10, 2026, outlines various compensatory arrangements. These include salary continuation for 12 months, a lump sum severance payment, a 2025 bonus payment, and reimbursements for legal and healthcare expenses. The agreement also details terms for continued vesting and extended exercise periods for stock options.
Key Highlights
- Craig Tooman's employment with Silence Therapeutics ended December 14, 2025.
- Separation Agreement entered into on July 10, 2026.
- Salary continuation for 12 months totaling $655,000.
- One-time lump sum cash severance payment of $250,000.
- Lump sum bonus payment of $283,746.03 for 2025.
- Reimbursement of legal fees up to $40,000.
- Reimbursement of healthcare premium totaling $46,896.48.
- Up to $20,000 for tax provider fees.
Price Impact
More from SLN